Advertisement

Topics

"Ophthalmic Lasers Medical Devices Pipeline Assessment 2017 Updated" Drugs and Medication Database: Page 20

21:38 EDT 18th March 2019 | BioPortfolio

Here are the most relevant "Ophthalmic Lasers Medical Devices Pipeline Assessment 2017 Updated" Drugs and Medications that we have found in our database.

More Information about "Ophthalmic Lasers Medical Devices Pipeline Assessment 2017 Updated" on BioPortfolio

We have published hundreds of Ophthalmic Lasers Medical Devices Pipeline Assessment 2017 Updated news stories on BioPortfolio along with dozens of Ophthalmic Lasers Medical Devices Pipeline Assessment 2017 Updated Clinical Trials and PubMed Articles about Ophthalmic Lasers Medical Devices Pipeline Assessment 2017 Updated for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Ophthalmic Lasers Medical Devices Pipeline Assessment 2017 Updated Companies in our database. You can also find out about relevant Ophthalmic Lasers Medical Devices Pipeline Assessment 2017 Updated Drugs and Medications on this site too.

Showing "Ophthalmic Lasers Medical Devices Pipeline Assessment 2017 Updated" Drugs and Medications 476–500 of 717

Possibly Relevant

Erythromycin [lake erie medical dba quality caer products llc]

Erythromycin Ophthalmic Ointment USP, 0.5%

Letrozole [sun pharmaceutical industries limited ]

These highlights do not include all the information needed to use LETROZOLE TABLETS safely and effectively. See full prescribing information for LETROZOLE TABLETS. LETROZOLE tablets, for oral use Initial U.S. Approval: 1997

Letrozole [apotex corp.]

These highlights do not include all the information needed to use LETROZOLE TABLETS safely and effectively.See full prescribing information for LETROZOLE TABLETS. LETROZOLE tablets, for oral use Initial U.S. Approval: 1997

Dextrose [hospira, inc.]

NA

Isopto atropine [alcon laboratories, inc.]

These highlights do not include all the information needed to use ISOPTO® ATROPINE safely and effectively. See full prescribing information for ISOPTO® ATROPINE ISOPTO® ATROPINE (atropine sulfate ophthalmic solution) 1%, for topical  ophthalmic useIni

Polymyxin b sulfate and trimethoprim [proficient rx lp]

Polymyxin B Sulfate and Trimethoprim Ophthalmic Solution USP*

Polymyxin b sulfate and trimethoprim [aidarex pharmaceuticals llc]

Polymyxin B Sulfate and Trimethoprim Ophthalmic Solution, USP*

Bimatoprost [sandoz inc]

These highlights do not include all the information needed to use BIMATOPROST OPHTHALMIC SOLUTION safely and effectively. See full prescribing information for BIMATOPROST OPHTHALMIC SOLUTION.BIMATOPROST Ophthalmic Solution, 0.03%Initial U.S. Approval: 200

Letrozole [west-ward pharmaceuticals corp.]

These highlights do not include all the information needed to use LETROZOLE TABLETS safely and effectively. See full prescribing information for LETROZOLE TABLETS.LETROZOLE tablets, for oral use Initial U.S. Approval: 1997

Polymyxin b sulfate and trimethoprim [preferred pharmaceuticals inc.]

Polymyxin B Sulfate and Trimethoprim Ophthalmic Solution, USP*

Letrozole [accord healthcare, inc.]

These highlights do not include all the information needed to use letrozole tablets safely and effectively. See full prescribing information for letrozole tablets. LETROZOLE tablets, for oral use Initial U.S. Approval: 1997

Nystatin [preferred pharmaceuticals inc.]

Nystatin Cream USP, 100,000 units per gram

Cyclopentolate hydrochloride [a-s medication solutions]

Cyclopentolate Hydrochloride Ophthalmic Solution USP

Letrozole [bryant ranch prepack]

These highlights do not include all the information needed to use letrozole tablets safely and effectively. See full prescribing information for letrozole tablets. LETROZOLE tablets, for oral use Initial U.S. Approval: 1997

Allergenic extracts standardized mite [greer laboratories, inc.]

These highlights do not include all the information needed to use Greer Standardized Mite Extracts safely and effectively. See full prescribing information for Greer Standardized Mite Extracts.Standardized Mite Extract (Dermatophagoides farinae) Standardi

Letrozole [aurobindo pharma limited]

These highlights do not include all the information needed to use LETROZOLE TABLETS safely and effectively. See full prescribing information for LETROZOLE TABLETS. LETROZOLE tablets, for oral use Initial U.S. Approval: 1997

Sulfacetamide sodium [preferred pharmaceuticals, inc]

Sulfacetamide Sodium Ophthalmic Solution USP, 10% (Sterile)

Polymyxin b sulfate and trimethoprim [nucare pharmaceuticals,inc.]

Polymyxin B Sulfate and Trimethoprim Ophthalmic Solution, USP*

Vigamox [a-s medication solutions]

These highlights do not include all the information needed to use VIGAMOX® solution safely and effectively. See full prescribing information for VIGAMOX®.VIGAMOX® (moxifloxacin ophthalmic solution) 0.5% Sterile topical ophthalmic solutionInitial U.S. A

Letrozole [jiangsu hengrui medicine co., ltd.]

These highlights do not include all the information needed to use LETROZOLE TABLETS safely and effectively. See full prescribing information for LETROZOLE TABLETS. LETROZOLE tablets, for oral use Initial U.S. Approval: 1997

Polymyxin b sulfate and trimethoprim [physicians total care, inc.]

Polymyxin B Sulfate andTrimethoprim Ophthalmic Solution USP*

Vigamox [alcon laboratories, inc.]

These highlights do not include all the information needed to use VIGAMOX® solution safely and effectively. See full prescribing information for VIGAMOX®.VIGAMOX® (moxifloxacin ophthalmic solution) 0.5% Sterile topical ophthalmic solutionInitial U.S. A

Nystatin [cadila healthcare limited]

Nystatin Ointment USPFor Topical Use OnlyNot for Ophthalmic Use

Prednisolone sodium phosphate [bausch & lomb incorporated]

Prednisolone Sodium Phosphate Ophthalmic Solution USP, 1% (Sterile)

Epinastine hydrochloride [somerset therapeutics, llc]

These highlights do not include all the information needed to use Epinastine HCl safely and effectively. See full prescribing information for Epinastine HCl. Epinastine HCl Ophthalmic Solution 0.05% Initial U.S. Approval: 2003



Advertisement
Quick Search
Advertisement
Advertisement